Consistent with this possibility, we observed multiple ligand-independent Notch1 mutations in Notch3−/− tumors that are sufficient to drive leukemogenesis of T-ALL (data not shown), as well as activation of the Notch1 signaling pathway. This evidence concerns the gene NOTCH3 and acute lymphoblastic leukemia.